Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2023

Month: May

Request Number: A-2022-001499

Request Summary: The initial cover letter indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2023-02-24 for the medicinal ingredient aprepitant. The Screening Acceptance Letter from Health Canada to the generic drug manufacturer confirming completion of screening of the Abbreviated New Drug Submission (ANDS) for aprepitant which appears in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2023-02-24.

Disposition: Disclosed in part

Number of pages: 3

Date modified: